These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16287518)

  • 1. [Organ transplants for HIV-infected patients--time for reevaluation?].
    Katzenstein TL
    Ugeskr Laeger; 2005 Nov; 167(46):4356-8. PubMed ID: 16287518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.
    Marfo K; Greenstein S
    Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal transplantation in HIV-infected patients in Spain].
    Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
    Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-organ transplantation in HIV-infected patients in the potent antiretroviral therapy era.
    Roland ME
    Top HIV Med; 2004; 12(3):73-6. PubMed ID: 15310937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid organ transplantation in HIV-infected recipients.
    El Sayegh S; Keller MJ; Huprikar S; Murphy B
    Pediatr Transplant; 2004 Jun; 8(3):214-21. PubMed ID: 15176956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
    Ciuffreda D; Pantaleo G; Pascual M
    Transpl Int; 2007 Aug; 20(8):649-58. PubMed ID: 17425723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical management of the HIV-positive kidney transplant recipient.
    Carlson L
    Nephrol Nurs J; 2008; 35(6):559-67; quiz 568. PubMed ID: 19260607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
    Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
    J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving clinical strategies for transplantation in the HIV-positive recipient.
    Stock PG; Roland ME
    Transplantation; 2007 Sep; 84(5):563-71. PubMed ID: 17876267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of transplantation in HIV patients during the HAART era.
    Pelletier SJ; Norman SP; Christensen LL; Stock PG; Port FK; Merion RM
    Clin Transpl; 2004; ():63-82. PubMed ID: 16704139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation in HIV-infected patients.
    Wyatt CM; Murphy B
    Semin Dial; 2005; 18(6):495-8. PubMed ID: 16398712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series.
    Landin L; Rodriguez-Perez JC; Garcia-Bello MA; Cavadas PC; Thione A; Nthumba P; Blanes M; Ibañez J
    Nephrol Dial Transplant; 2010 Sep; 25(9):3106-15. PubMed ID: 20228071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?
    Miró JM; Laguno M; Moreno A; Rimola A;
    J Hepatol; 2006; 44(1 Suppl):S140-5. PubMed ID: 16352366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.
    Busnach G; Piselli P; Arbustini E; Baccarani U; Burra P; Carrieri MP; Citterio F; De Juli E; Bellelli S; Pradier C; Rezza G; Serraino D;
    Transplant Proc; 2006 Dec; 38(10):3533-5. PubMed ID: 17175324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplants in HIV patients?
    Coleman T; Culkin C; Sierka D
    RN; 2006 Jan; 69(1):33-8; quiz 39. PubMed ID: 16441002
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions].
    Moretto J; Bessard G; Stanke-Labesque F
    Therapie; 2007; 62(4):327-35. PubMed ID: 17983558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.